Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 577,616
  • Shares Outstanding, K 33,759
  • Annual Sales, $ 129,010 K
  • Annual Income, $ -6,680 K
  • 60-Month Beta -0.25
  • Price/Sales 4.44
  • Price/Cash Flow N/A
  • Price/Book 2.11
Trade TRDA with:

Options Overview Details

View History
  • Implied Volatility 72.86% ( -65.18%)
  • Historical Volatility 51.54%
  • IV Percentile 45%
  • IV Rank 27.96%
  • IV High 150.07% on 07/15/24
  • IV Low 42.89% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 54
  • Open Int (30-Day) 38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.65
  • Number of Estimates 3
  • High Estimate 1.23
  • Low Estimate -0.05
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +183.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.78 +24.67%
on 07/05/24
18.17 -5.45%
on 07/16/24
+2.33 (+15.69%)
since 06/21/24
3-Month
11.82 +45.35%
on 04/30/24
18.17 -5.45%
on 07/16/24
+4.29 (+33.28%)
since 04/23/24
52-Week
10.75 +59.81%
on 11/22/23
18.17 -5.45%
on 07/16/24
+0.12 (+0.70%)
since 07/21/23

Most Recent Stories

More News
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals hits record high on strong earnings, FDA approval for cystic fibrosis medication for infants. Analysts recently boosted price targets.

VRTX : 490.32 (-1.13%)
CRSP : 57.19 (+1.69%)
TRDA : 17.18 (+0.41%)
MRNA : 121.25 (-1.02%)
GILD : 71.17 (-1.71%)
AMGN : 333.24 (-0.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 17.18 (+0.41%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 17.18 (+0.41%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 17.18 (+0.41%)
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced a global collaboration focused on discovering and developing intracellular Endosomal...

VRTX : 490.32 (-1.13%)
TRDA : 17.18 (+0.41%)
Entrada Therapeutics Reports Second Quarter 2022 Financial Results

On track to submit Investigational New Drug application to the U.S. Food and Drug Administration for ENTR-601-44 targeting Duchenne muscular dystrophy in...

TRDA : 17.18 (+0.41%)
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer

BOSTON, July 19, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of...

TRDA : 17.18 (+0.41%)
Entrada Therapeutics to Present at William Blair Biotech Focus Conference

BOSTON, July 06, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of...

TRDA : 17.18 (+0.41%)
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of...

TRDA : 17.18 (+0.41%)
Entrada Therapeutics Reports First Quarter 2022 Financial Results

Second clinical candidate, ENTR-701, announced for the potential treatment of myotonic dystrophy type 1 On track to submit Investigational New Drug...

TRDA : 17.18 (+0.41%)

Business Summary

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 19.10
2nd Resistance Point 18.51
1st Resistance Point 17.85
Last Price 17.18
1st Support Level 16.60
2nd Support Level 16.01
3rd Support Level 15.35

See More

52-Week High 18.17
Last Price 17.18
Fibonacci 61.8% 15.34
Fibonacci 50% 14.46
Fibonacci 38.2% 13.58
52-Week Low 10.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar